CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 190 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $116,900 | -13.0% | 10,000 | 0.0% | 0.12% | -13.3% |
| Q2 2023 | $134,400 | -18.9% | 10,000 | 0.0% | 0.14% | -21.5% |
| Q1 2023 | $165,800 | +89039.8% | 10,000 | 0.0% | 0.17% | -19.2% |
| Q4 2022 | $186 | -99.9% | 10,000 | 0.0% | 0.21% | +29.9% |
| Q3 2022 | $128,000 | +82.9% | 10,000 | 0.0% | 0.16% | +100.0% |
| Q2 2022 | $70,000 | -15.7% | 10,000 | 0.0% | 0.08% | +3.8% |
| Q1 2022 | $83,000 | +22.1% | 10,000 | 0.0% | 0.08% | +25.4% |
| Q4 2021 | $68,000 | – | 10,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 208,189 | $1,726,000 | 3.48% |
| FRIESS ASSOCIATES LLC | 571,940 | $4,741,000 | 2.53% |
| GABLES CAPITAL MANAGEMENT INC. | 438,764 | $3,637,000 | 2.28% |
| Prairiewood Capital, LLC | 258,073 | $2,139,000 | 1.50% |
| Quantedge Capital Pte Ltd | 597,300 | $4,952,000 | 1.46% |
| ARMISTICE CAPITAL, LLC | 8,372,000 | $69,404,000 | 1.34% |
| SummerHaven Investment Management, LLC | 158,473 | $1,314,000 | 0.74% |
| Capital Impact Advisors, LLC | 99,322 | $823,000 | 0.60% |
| EAM Investors, LLC | 365,415 | $3,029,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 304,515 | $2,524,000 | 0.51% |